Rubius Therapeutics Inc (NASDAQ:RUBY)

Delayed Data
As of Aug 09
 +0.0071 / +0.90%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 2.50, with a high estimate of 15.00 and a low estimate of 1.00. The median estimate represents a +212.46% increase from the last price of 0.80.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Rubius Therapeutics Inc. This rating has held steady since June, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
Growthannually 11.93%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.